|
Platelet Membrane Glycoprotein IIB Peptide (296-306)
|
GLYCOPROTEIN IIB FRAGMENT (296-306)
|
|
|
Hsp Heat shock protein (3-13)
|
LYS-THR-ILE-ALA-TYR-ASP-GLU-GLU-ALA-ARG-ARG
|
|
|
HPV-E6-N
|
ASP-PRO-GLN-GLU-ARG-PRO-ARG-LYS-LEU-PRO-GLN-LEU-CYS-THR-GLU
|
|
|
Head activator (7-11)
|
HEAD ACTIVATOR (7-11)
|
|
|
HPV-E7-N
|
TYR-MET-LEU-ASP-LEU-GLN-PRO-GLU-THR-THR-ASP-LEU-TYR-CYS-TYR-GLU-GLN-LEU-ASN-ASP
|
|
|
Gluten Exorphin A5
|
GLY-TYR-TYR-PRO-THR
|
|
|
Rcramp
|
GLY-LEU-VAL-ARG-LYS-GLY-GLY-GLU-LYS-PHE-GLY-GLU-LYS-LEU-ARG-LYS-ILE-GLY-GLN-LYS-ILE-LYS-GLU-PHE-PHE-GLN-LYS-LEU-ALA-LEU-GLU-ILE-GLU-GLN
|
|
|
Rigin
|
GLY-GLN-PRO-ARG
|
77727-17-4
|
|
Hemoglobin (Hb) (64-76)
|
GLY-LYS-LYS-VAL-ILE-THR-ALA-PHE-ASN-GLU-GLY-LEU-LYS
|
|
|
Glycogen Synthase-derived peptide
|
LYS-LYS-LEU-ASN-ARG-THR-LEU-SER-VAL-ALA
|
|
|
Locustachykinin I
|
GLY-PRO-SER-GLY-PHE-TYR-GLY-VAL-ARG-NH2
|
|
|
Glycoprotein Hormone a (32-46) amide
|
CYS-PHE-SER-ARG-ALA-TYR-PRO-THR-PRO-LEU-ARG-SER-LYS-LYS-THR-NH2
|
|
|
G-P-R
|
GLY-PRO-ARG
|
|
|
HER2/neu (869-877)
|
LEU-LEU-ASP-ILE-ASP-GLU-THR-GLU-TYR
|
|
|
RES-701-3
|
GLY-ASN-TRP-HIS-GLY-THR-SER-PRO-ASP-TRP-PHE-PHE-ASN-TYR-TYR-TRP
|
|
|
Hemorphin-7
|
TYR-PRO-TRP-THR-GLN-ARG-PHE
|
|
|
Morphine Modulating Peptide, C-Terminal Fragment
|
H-PRO-GLN-ARG-PHE-NH2
|
|
|
Head activator
|
GLP-PRO-PRO-GLY-GLY-SER-LYS-VAL-ILE-LEU-PHE
|
|
|
HPV-E6-C
|
PRO-LEU-CYS-PRO-GLU-GLU-LYS-GLN-ARG-HIS-LEU-ASP-LYS-LYS-GLN-ARG-PHE-HIS-ASN-ILE
|
|
|
Necrofibrin, human
|
GLY-ALA-VAL-SER-THR-ALA
|
|
|
GnT-V (nt38-67)
|
VAL-LEU-PRO-ASP-VAL-PHE-ILE-ARG-CYS-VAL
|
|
|
I-309 (human)
|
LYS-SER-MET-GLN-VAL-PRO-PHE-SER-ARG-CYS-CYS-PHE-SER-PHE-ALA-GLU-GLN-GLU-ILE-PRO-LEU-ARG-ALA-ILE-LEU-CYS-TYR-ARG-ASN-THR-SER-SER-ILE-CYS-SER-ASN-GLU-GLY-LEU-ILE-PHE-LYS-LEU-LYS-ARG-GLY-LYS-GLU-ALA-CYS-ALA-LEU-ASP-THR-VAL-GLY-TRP-VAL-GLN-ARG-HIS-ARG-LYS-MET
|
|
|
Human Papillomavirus E7 protein (49 - 57)
|
ARG-ALA-HIS-TYR-ASN-ILE-VAL-THR-PHE
|
|
|
Forkhead derived peptide, Woodtide
|
LYS-LYS-ILE-SER-GLY-ARG-LEU-SER-PRO-ILE-MET-THR-GLU-GLN-NH2
|
|
|
HPV-E6-M
|
SER-GLU-TYR-PRO-HIS-TYR-CYS-TYR-SER-LEU-TYR-GLY-THR-THR-LEU-GLU-GLN-GLN-TYR-ASN
|
|
|
K-R-Q-H-P-G
|
LYS-ARG-GLN-HIS-PRO-GLY
|
|
|
NubO (68-75), Ndufa4 (68-75)
|
VAL-ASN-VAL-ASP-TYR-SER-LYS-LEU
|
|
|
NPF
|
LYS-ARG-SER-TYR(PO3H2)-GLU-GLU-HIS-ILE-PRO
|
|
|
MSP-1 P2, Malaria Merozoite Surface Peptide – 1
|
GLY-TYR-ARG-LYS-PRO-LEU-ASP-ASN-ILE-LYS-ASP-ASN-VAL-GLY-LYS-MET-GLU-ASP-TYR-ILE-LYS-LYS
|
|
|
P61 (343-355), M. leprae
|
ARG-VAL-ALA-GLN-ILE-ARG-THR-GLU-ILE-GLU-ASN-SER-ASP
|
|
|
Murine CMV pp 89 (170-174)
|
HIS-PHE-MET-PRO-THR
|
|
|
Kemptide Negative Control
|
LEU-ARG-ARG-ALA-ALA-LEU-GLY
|
|
|
Neo-Kyotorphin
|
NEO-KYOTORPHIN
|
|
|
Leucomyosuppressin (lms)
|
PYR-ASP-VAL-ASP-HIS-VAL-PHE-LEU-ARG-PHE-NH2
|
|
|
PAKtide
|
ARG-ARG-ARG-LEU-SER-PHE-ALA-GLU-PRO-GLY
|
|
|
NES Topoisomerase II alpha (1017-1028)
|
ASP-ILE-LEU-ARG-ASP-PHE-PHE-GLU-LEU-ARG-LEU-LYS
|
|
|
Myristoylated ADP-Ribosylation Factor 1, myr-ARF1 (2-17)
|
MYRISTOYL -GLY-ASN-ILE-PHE-ALA-ASN-LEU-PHE-LYS-GLY-LEU-PHE-GLY-LYS-LYS-GLU
|
|
|
Myristoylated ADP-Ribosylation Factor 6, myr-ARF6 (2-13)
|
MYRISTOYL -GLY-LYS-VAL-LEU-SER-LYS-ILE-PHE-GLY-ASN-LYS-GLU
|
|
|
p3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54–68)
|
PHE-GLU-ALA-LYS-GLY-ALA-LYS-ALA-ASN-LYS-ALA-VAL-ASP
|
|
|
KL-1
|
LEU-PRO-PRO-VAL-ALA-ALA-SER-SER-LEU-ARG-ASN-ASP
|
|
|
P38 (411-425), M. leprae
|
ALA-GLY-GLY-GLY-VAL-THR-LEU-LEU-GLN-ALA-ALA-PRO-ALA-LEU-ASP
|
|
|
IP3R-derived Peptide
|
GLY-ARG-ARG-GLU-SER-LEU-THR-SER-PHE-GLY-NH2
|
|
|
Lytic Peptide, SB-37
|
LYTIC PEPTIDE SHIVA-1
|
|
|
LMP2 (236-244) , RRR
|
ARG-ARG-ARG-TRP-ARG-ARG-LEU-THR-VAL
|
|
|
LMP1 (156-164),IAL
|
ILE-ALA-LEU-TYR-LEU-GLN-GLN-ASN-TRP
|
|
|
NPV
|
棉鈴蟲核多角體病毒
|
|
|
LMP1,TDD
|
THR-ASP-ASP-SER-GLY-HIS-GLU-SER-ASP-SER-ASN-SER-ASN-GLU-GLY-ARG-HIS
|
|
|
Nuclear Export Signal, NES, PKI
|
GLU-LEU-ALA-LEU-LYS-LEU-ALA-GLY-LEU-ASP-ILE-ASN
|
|
|
N-10 Region of TRAP
|
ASP-GLU-ILE-LYS-TYR-SER-GLU-GLU-VAL-CYS
|
|
|
MSP-1 (20-39), Merozoite Surface Peptide 1
|
VAL-THR-HIS-GLU-SER-TYR-GLN-GLU-LEU-VAL-LYS-LYS-LEU-GLU-ALA-LEU-GLU-ASP-ALA-VAL
|
|
|
KK4A
|
LYS-LYS-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-VAL-LEU-SER-GLY-LYS
|
|
|
Myomodulin
|
PRO-MET-SER-MET-LEU-ARG-LEU-NH2
|
|
|
OV-2, Sheep
|
LEU-ARG-ARG-ILE-ILE-ARG-LYS-ILE-ILE-HIS-ILE-ILE-LYS-LYS-NH2
|
|
|
Metamorphosin A
|
METAMORPHOSIN A
|
|
|
IRS1-derived peptide
|
LYS-LYS-SER-ARG-GLY-ASP-TYR-MET-THR-MET-GLN-ILE-GLY-NH2
|
|
|
LEAP-2 (38-77) (Human)
|
MET-THR-PRO-PHE-TRP-ARG-GLY-VAL-SER-LEU-ARG-PRO-ILE-GLY-ALA-SER-CYS-ARG-ASP-ASP-SER-GLU-CYS-ILE-THR-ARG-LEU-CYS-ARG-LYS-ARG-ARG-CYS-SER-LEU-SER-VAL-ALA-GLN-GLU
|
|
|
IELLQAR (8-branch MAPS) Selectin Binding Peptide
|
ILE-GLU-LEU-LEU-GLN-ALA-ARG
|
|
|
LKRApYLG-NH2
|
LEU-LYS-ARG-ALA-PTYR-LEU-GLY-NH2
|
|
|
Ketolide resistance Peptide MRFFV
|
H-MET-ARG-PHE-PHE-VAL-OH
|
|
|
Leucopyrokinin (LPK)
|
LEUCOPYROKININ
|
|
|
MKKp2
|
SER-LYS-GLY-LYS-SER-LYS-ARG-LYS-LYS-ASP-LEU-ARG-ILE-SER-CYS-ASN-SER-LYS
|
|
|
MARCKS Protein (159-165)
|
PHE-LYS-LYS-SER-PHE-LYS-LEU
|
|
|
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
|
MET-LEU-ALA-ARG-ARG-LYS-LYS-VAL-TYR-PRO-TYR-PRO-MET-GLU-PRO-THR-ILE-ALA-GLU-GLY-NH2
|
|
|
Invertebrate Tachykinin-I, OctTK-I
|
LYS-PRO-PRO-SER-SER-SER-GLU-PHE-ILE-GLY-LEU-MET-NH2
|
|
|
LMP2 (419-427), TYG
|
THR-TYR-GLY-PRO-VAL-PHE-MET-CYS-LEU
|
|
|
Urechistachykinin I
|
LEU-ARG-GLN-SER-GLN-PHE-VAL-GLY-SER-ARG-NH2
|
|
|
PLM derived peptide
|
ILE-ARG-ARG-LEU-SER-THR-ARG-ARG-ARG
|
|
|
PDGFRtide
|
GLN-GLU-GLU-GLU-TYR-VAL-PHE-ILE-GLU
|
|
|
proPT18
|
HIS-VAL-PHE-LEU-ALA-PRO-GLN-GLN-ALA-ARG-SER-LEU-LEU-GLN-ARG-VAL-ARG-ARG
|
|
|
p3K, (Lys 58 Lys 60 Lys 63) Ea(52–68)
|
ALA-SER-PHE-GLU-ALA-GLN-LYS-ALA-LYS-ALA-ASN-LYS-ALA-VAL-ASP-LYS-ALA
|
|
|
pro-ε-Tx1X/12
|
LEU-LYS-ARG-THR-ILE-ARG-THR-ARG-LEU-ASN-ILE-ARG
|
|
|
PRRS-RSAB-C
|
LEU-ASN-GLY-THR-ASP-TRP-LEU-SER-ASN-HIS-PHE-ASP-TRP-ALA
|
|
|
Peptide B, bovine
|
PHE-ALA-GLU-PRO-LEU-PRO-SER-GLU-GLU-GLU-GLY-GLU-SER-TYR-SER-LYS-GLU-VAL-PRO-GLU-MET-GLU-LYS-ARG-TYR-GLY-GLY-PHE-MET-ARG-PHE
|
|
|
Sturgeon F
|
PHE-GLY-GLY-PHE-MET-LYS-GLY-LYS-TYR-GLY-TYR
|
|
|
Pep 4AK
|
LYS-LYS-LYS-GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-ILE-LEU-SER-GLY-ARG-NH2
|
|
|
Peptide Standard 1
|
PEPTIDE STANDARD 1
|
|
|
Phyllomedusin
|
PHYLLOMEDUSIN
|
|
|
Pep-1
|
LYS-GLU-THR-TRP-TRP-GLU-THR-TRP-TRP-THR-GLU-TRP-SER-GLN-PRO-LYS-LYS-LYS-ARG-LYS-VAL
|
|
|
Pre-S1 (12-32)
|
MET-GLY-THR-ASN-LEU-SER-VAL-PRO-ASN-PRO-LEU-GLY-PHE-PHE-PRO-ASP-HIS-GLN-LEU-ASP-PRO
|
|
|
Pro-TGF-a
|
HIS-ALA-ASP-LEU-LEU-ALA-VAL-VAL-ALA-ALA-SER-GLN
|
|
|
Rnase (90-105)
|
SER-LYS-TYR-PRO-ASN-CYS-ALA-TYR-LYS-THR-THR-GLN-ALA-ASN-LYS-HIS
|
|
|
proFIX18
|
THR-VAL-PHE-LEU-ASP-HIS-GLU-ASN-ALA-ASN-LYS-ILE-LEU-ASN-ARG-PRO-LYS-ARG
|
|
|
R-JAG (188-206) R-Jagged-1(188-206), Notch Ligand
|
CYS-ASP-ASP-TYR-TYR-TYR-GLY-PHE-GLY-CYS-ASN-LYS-PHE-GLY-ARG-PRO-ARG-ASP-ASP
|
|
|
proPT28
|
HIS-VAL-PHE-LEU-ALA-PRO-GLN-GLN-ALA-ARG-SER-LEU-LEU-GLN-ARG-VAL-ARG-ARG-ALA-ASN-THR-PHE-LEU-GLU-GLU-VAL-ARG-LYS
|
|
|
Pep 4A
|
GLY-SER-VAL-VAL-ILE-VAL-GLY-ARG-ILE-ILE-LEU-SER-GLY-ARG-NH2
|
|
|
Sendai Virus Nucleoprotein (SV9), 324-332
|
PHE-ALA-PRO-GLY-ASN-TYR-PRO-ALA-LEU
|
|
|
PRRS-PQGAB-C
|
GLY-THR-ASP-TRP-LEU-ALA-ASN-LYS-PHE-ASP-TRP-ALA
|
|
|
Prosaptide, wild type
|
THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
|
p34cdc2-derived peptide
|
LYS-VAL-GLU-LYS-ILE-GLY-GLU-GLY-THR-TYR-GLY-VAL-VAL-NH2
|
|
|
RSV M (187-195)
|
ASN-ALA-ILE-THR-ASN-ALA-LYS-ILE-ILE
|
|
|
P62 (417-429), M. leprae
|
LEU-LEU-GLN-ALA-ALA-PRO-ALA-LEU-ASP-LYS-LEU-LYS-LEU
|
|
|
Prosaptide 769P
|
CYS-D-ALA-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
|
P69 (522-534), M. leprae
|
PRO-GLU-LYS-THR-ALA-ALA-PRO-ALA-SER-ASP-PRO-THR-GLY
|
|
|
Prepro-Nerve Growth Factor (99-115) (mouse)
|
PRO-GLU-ALA-HIS-TRP-THR-LYS-LEU-GLN-HIS-SER-LEU-ASP-THR-ALA-LEU-ARG
|
|
|
PRRS-PQGAB-M
|
THR-TYR-ALA-SER-ASN-ASP-SER-SER-SER-HIS-LEU-GLN
|
|
|
Peptide F, bovine
|
TYR-GLY-GLY-PHE-MET-LYS-LYS-MET-ASP-GLU-LEU-TYR-PRO-LEU-GLU-VAL-GLU-GLU-GLU-ALA-ASN-GLY-GLY-GLU-VAL-LEU-GLY-LYS-ARG-TYR-GLY-GLY-PHE-MET
|
|
|
proFIX28
|
THR-VAL-PHE-LEU-ASP-HIS-GLU-ASN-ALA-ASN-LYS-ILE-LEU-ASN-ARG-PRO-LYS-ARG-TYR-ASN-SER-GLY-LYS-LEU-GLU-GLU-PHE-VAL
|
|
|
PRRS-PQGAB-N
|
GLY-SER-SER-LEU-ASP-ASP-PHE-CYS-TYR-ASP-SER-THR
|
|
|
PRRS-RSAB-N
|
ALA-GLY-GLY-SER-SER-SER-THR-TYR-GLN-TYR
|
|
|
SALMF amide 2 (S2)
|
SER-GLY-PRO-TYR-SER-PHE-ASN-SER-GLY-LEU-THR-PHE-NH2
|
|